Effect of Gestational Diabetes Mellitus on Newborn Hearing: A Systematic Review

Komal Aggarwal1, Rohit Ravi2

  • 1Department of Audiology and Speech-Language Pathology, Amity Medical School, Amity University Haryana, Gurugram, India.

Insights

Gestational diabetes mellitus (GDM) increases the risk of hearing loss in newborns. Infants born to mothers with GDM show higher hearing screening referral rates, indicating a need for early detection.

Area of Science:

  • Neonatal Health
  • Audiology
  • Endocrinology

Background:

  • Gestational diabetes mellitus (GDM) is linked to adverse neonatal outcomes.
  • The impact of GDM on newborn hearing sensitivity remains under-explored.

Approach:

  • A systematic literature review was performed using PubMed, Scopus, and CHINAL databases.
  • Keywords included "gestational diabetes," "diabetic pregnancies," "hearing loss," "hearing impairment," and "hearing disorder."
  • Seven relevant articles were selected and analyzed.

Key Points:

  • Newborns from GDM pregnancies exhibit a higher prevalence of hearing loss.
  • Higher referral rates were observed in the initial hearing screenings for GDM infants.
  • Infants of diabetic pregnancies are at increased risk for bilateral, particularly sensorineural, hearing loss.

Conclusions:

  • GDM is associated with an elevated risk of hearing impairment in newborns.
  • Early detection and intervention through multidisciplinary collaboration are crucial for affected infants.
Abstract

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
894
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K